These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31450946)

  • 21. Progress in the search for circulating biomarkers of nonalcoholic fatty liver disease.
    Amacher DE
    Biomarkers; 2014 Nov; 19(7):541-52. PubMed ID: 25189636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of the index of NASH - ION for the diagnosis of steatohepatitis in patients with non-alcoholic fatty liver: An external validation study.
    Younes R; Rosso C; Petta S; Cucco M; Marietti M; Caviglia GP; Ciancio A; Abate ML; Cammà C; Smedile A; Craxì A; Saracco GM; Bugianesi E
    Liver Int; 2018 Apr; 38(4):715-723. PubMed ID: 29028281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reply-letter to the editor: Copper deficiency and nonalcoholic fatty liver disease: The chicken or the egg?
    Lan Y; Wang L
    Clin Nutr; 2021 Nov; 40(11):5445-5446. PubMed ID: 34653824
    [No Abstract]   [Full Text] [Related]  

  • 24. Reply-Letter to the Editor-Is liver steatosis diagnostic of non-alcoholic fatty liver disease in patients with hereditary fructose intolerance?
    Aldamiz-Echevarria L; Villate O
    Clin Nutr; 2019 Aug; 38(4):1962. PubMed ID: 31104878
    [No Abstract]   [Full Text] [Related]  

  • 25. The impact of non-alcoholic fatty liver disease fibrosis score on cardiac prognosis in patients with chronic heart failure.
    Takahashi T; Watanabe T; Shishido T; Watanabe K; Sugai T; Toshima T; Kinoshita D; Yokoyama M; Tamura H; Nishiyama S; Arimoto T; Takahashi H; Yamanaka T; Miyamoto T; Kubota I
    Heart Vessels; 2018 Jul; 33(7):733-739. PubMed ID: 29288403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum Immunoglobulin A Levels Do Not Correlate With Liver Disease Severity in Pediatric Nonalcoholic Fatty Liver Disease.
    Mouzaki M; Bramlage K; Arce-Clachar AC; Xanthakos SA
    J Pediatr Gastroenterol Nutr; 2018 Nov; 67(5):631-634. PubMed ID: 30363043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum cytokeratin-18 fragment levels as noninvasive marker of nonalcoholic steatohepatitis in the chilean population.
    Arab JP; Hernández-Rocha C; Morales C; Vargas JI; Solís N; Pizarro M; Robles C; Sandoval D; Ponthus S; Benítez C; Barrera F; Soza A; Riquelme A; Arrese M
    Gastroenterol Hepatol; 2017; 40(6):388-394. PubMed ID: 28359548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reply to the Letter to the Editor: Derivation and Internal Validation of a Clinical Prediction Tool to Predict Nonalcoholic Fatty Liver Disease in Patients With Crohn's Disease.
    McHenry S; Ciorba MA; Deepak P
    Inflamm Bowel Dis; 2020 May; 26(6):e46. PubMed ID: 32130410
    [No Abstract]   [Full Text] [Related]  

  • 29. Reply to the Letter to the Editor by Li et al.: Bioinformatics Analysis in Mice with Diet-Induced Nonalcoholic Steatohepatitis Treated with Astaxanthin and Vitamin E.
    Kobori M; Takahashi Y; Sakurai M; Ni Y; Chen G; Nagashimada M; Kaneko S; Ota T
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28475150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response to letter to the editor: impact of bariatric surgery on outcomes of patients with nonalcoholic fatty liver disease: a nationwide inpatient sample analysis, 2004-2012.
    McCarty TR; Echouffo-Tcheugui JB; Lange A; Haque L; Njei B
    Surg Obes Relat Dis; 2018 May; 14(5):726. PubMed ID: 29576483
    [No Abstract]   [Full Text] [Related]  

  • 31. Letter to the Editor: Bone Health in Nonalcoholic Fatty Liver Disease: A Mechanistic Insight.
    Sugiyama T
    Hepatology; 2019 Nov; 70(5):1872. PubMed ID: 31099070
    [No Abstract]   [Full Text] [Related]  

  • 32. Cost-Effectiveness Analysis: Risk Stratification of Nonalcoholic Fatty Liver Disease (NAFLD) by the Primary Care Physician Using the NAFLD Fibrosis Score.
    Tapper EB; Hunink MG; Afdhal NH; Lai M; Sengupta N
    PLoS One; 2016; 11(2):e0147237. PubMed ID: 26905872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The evaluation of hepatic fibrosis scores in children with nonalcoholic fatty liver disease.
    Mansoor S; Yerian L; Kohli R; Xanthakos S; Angulo P; Ling S; Lopez R; Christine CK; Feldstein AE; Alkhouri N
    Dig Dis Sci; 2015 May; 60(5):1440-7. PubMed ID: 25540086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonalcoholic steatohepatitis is associated with a state of betaine-insufficiency.
    Sookoian S; Puri P; Castaño GO; Scian R; Mirshahi F; Sanyal AJ; Pirola CJ
    Liver Int; 2017 Apr; 37(4):611-619. PubMed ID: 27614103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Letter to the Editor: Suggestions for Rational Management of Nonalcoholic Fatty Liver Disease.
    Luo L; Zou H; Zheng S; Duan Z; Chen Y
    Hepatology; 2019 Oct; 70(4):1492-1493. PubMed ID: 31152594
    [No Abstract]   [Full Text] [Related]  

  • 36. Letter to the Editor: Quantitative Histological Assessment in Nonalcoholic Fatty Liver Disease.
    Gawrieh S; Kleiner DE; Chalasani N; Vanderbeck S
    Hepatology; 2020 Aug; 72(2):785. PubMed ID: 32043611
    [No Abstract]   [Full Text] [Related]  

  • 37. Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease.
    Chen Y; Xu M; Wang T; Sun J; Sun W; Xu B; Huang X; Xu Y; Lu J; Li X; Wang W; Bi Y; Ning G
    Atherosclerosis; 2015 Jul; 241(1):145-50. PubMed ID: 25988358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver fibrosis markers of nonalcoholic steatohepatitis.
    Enomoto H; Bando Y; Nakamura H; Nishiguchi S; Koga M
    World J Gastroenterol; 2015 Jun; 21(24):7427-35. PubMed ID: 26139988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease.
    Ajmera V; Perito ER; Bass NM; Terrault NA; Yates KP; Gill R; Loomba R; Diehl AM; Aouizerat BE;
    Hepatology; 2017 Jan; 65(1):65-77. PubMed ID: 27532276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD.
    Wang J; Li P; Jiang Z; Yang Q; Mi Y; Liu Y; Shi R; Zhou Y; Wang J; Lu W; Li S; Liu D
    Korean J Intern Med; 2016 May; 31(3):479-87. PubMed ID: 27025268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.